By Regulatory Approvals — FDA Clears Phase 2 Trial of B7-H3 CAR T MT027 for Brain Metastases Targeted Oncology
Read the original at Regulatory Approvals ↗
Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. October 12, 2026.